What is D’OXYVA? The D’OXYVA® device is a simple, commercially- available device to deliver transdermal carbon dioxide (CO2). It consists of a patented and patent-pending ergonomic polymer shell that is
NEW YORK—Cerebral blood flow (CBF) in healthy older people predicts cognitive function four years later, according to results from an arterial-spin-labeling perfusion-MRI study. “Specifically, we found that brain blood flow
ABSTRACT In neonates, cardiovascular system development does not stop after the transition from intra-uterine to extra-uterine life and is not limited to the macrocirculation. The microcirculation (MC), which is essential
Pasadena Award Program Honors the Achievement PASADENA August 31, 2016 — Circularity Healthcare, LLC has been selected for the 2016 Pasadena Award in the Healthcare Products Developer & Manufacturer category
Cor pulmonale has long been described in very severe chronic obstructive pulmonary disease (COPD) and emphysema. Cross-sectional results from population-based studies show that left ventricular filling and a variety of
Epidemiological studies have shown increased morbidity and mortality in patients with coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD). We aimed to characterize the oxygen dependence of endothelial
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.
Patients should always ask their doctors for medical advice about adverse events.
You may report an adverse event related to Circularity products by calling 1-855-536-9982 (US only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch.com or call 1-800-FDA-1088.